News & Articles

BIOFIRE® SPOTFIRE® R/ST Panel Mini is a fast, highly sensitive and targeted panel that tests for four of the most common respiratory viruses (including influenzas) and Streptococcus A, from one throat swab

Brand new event designed to bring together everyone working in the clinical laboratory science industry

Understand the importance of fostering cross-department collaboration for an optimal antimicrobial stewardship program

From the manufacture and supply of raw materials to risk mitigation and assay development capabilities, learn how Merck is helping IVD developers bring new devices to market

Explore the modern point-of-care ecosystem and its impact on healthcare delivery

Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization

An introduction to the challenges and considerations for clinical labs embarking on digital transformation in healthcare

A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways

Discover how modern quality control (QC) principles can enhance operational efficiency and healthcare outcomes

The new platform promises to substantially lower hands-on time, allowing for increased lab productivity

The new diagnostic system, which combines optofluidics and nanopores can test for COVID-19 and Zika virus

A study suggests that a subtype of Fusobacterium nucleatum underlies colorectal cancer growth in humans and could be useful in screening and treatments

Discover the human side of laboratory medicine with our #Lab4Life editorial feature

Annual ECCMID congress is now ESCMID Global

The analyzer can now function with new CE-Marked Hepatitis assays announced at ESCMID Global

Smartphone-sized laboratory – Sepsis IVD grade test based on cutting-edge BioMEMS technology is a joint development objective

This is the first four-in-one nucleic acid test for arbovirus screening

Point-of-care HIV diagnostic testing for infants and early detection of HIV infections

The cobas Malaria test is the first FDA-approved molecular test to screen US blood donors for malaria

The respiratory/sore throat (R/ST) panel receives Dual 510(k) clearance and CLIA-waiver approval

The Selux PBC Separator, part of the Next Generation Phenotyping (NGP) System, makes this the only FDA cleared, single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies

David Wells, CEO of the IBMS, discusses the Institute’s plans to ensure the future of biomedical science careers

Experts discuss the game-changing potential of novel host response-based diagnostics to combat the global challenge of antimicrobial resistance (AMR)